Literature DB >> 21651681

Survival of Mycobacterium tuberculosis during experimental aerosolization and implications for aerosol challenge models.

S O Clark1, Y Hall, D L F Kelly, G J Hatch, A Williams.   

Abstract

AIMS: We undertook a series of experiments to investigate factors that contribute to variation in Mycobacterium tuberculosis viability and infectivity, during experimental aerosolization, with an aim to optimize a strategy to enable a more reproducible delivered dose within animal models of tuberculosis. METHODS AND
RESULTS: The viability and infectivity of the challenge suspension was determined in relation to aerosolization time, concentration, method of preparation and M. tuberculosis strain. Challenge stocks generated from frozen aliquots of M. tuberculosis were shown to undergo a 1 log(10) CFU ml(-1) decrease in viability during the first 10 min of aerosolization. This correlated with a decrease in surface lung lesions developing in guinea pigs challenged during this time. The phenomenon of decreased viability in vitro was not observed when using freshly grown, nonfrozen cells of M. tuberculosis. The viability of aerosolized bacilli at the point of inhalation relative to the point of aerosolization always remained constant.
CONCLUSION: Based on these findings, we have developed an improved strategy by which to reproducibly deliver aerosol infection doses to individually challenged animals and separately challenged groups of animals. SIGNIFICANCE AND IMPACT OF THE STUDY: Study of the aerobiological characteristics of micro-organisms is a critical step in the validation of methodology for aerosol infection animal models, particularly where large numbers of animals and nonhuman primates are used.
© 2011 The Authors. Journal of Applied Microbiology © 2011 The Society for Applied Microbiology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21651681     DOI: 10.1111/j.1365-2672.2011.05069.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  16 in total

1.  Construction and Characterization of the Mycobacterium tuberculosis sigE fadD26 Unmarked Double Mutant as a Vaccine Candidate.

Authors:  Rogelio Hernandez-Pando; Sung Jae Shin; Simon Clark; Stefano Casonato; Martin Becerril-Zambrano; Hongmin Kim; Francesca Boldrin; Dulce Mata-Espinoza; Roberta Provvedi; Ainhoa Arbues; Brenda Marquina-Castillo; Laura Cioetto Mazzabò; Jorge Barrios-Payan; Carlos Martin; Sang-Nae Cho; Ann Williams; Riccardo Manganelli
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

2.  Correlates between models of virulence for Mycobacterium tuberculosis among isolates of the Central Asian lineage: a case for lysozyme resistance testing?

Authors:  Claire Pardieu; Nicola Casali; Simon O Clark; Richard Hooper; Ann Williams; Preya Velji; Ximena Gonzalo; Francis Drobniewski
Journal:  Infect Immun       Date:  2015-03-16       Impact factor: 3.441

Review 3.  Modeling tuberculosis in nonhuman primates.

Authors:  Charles A Scanga; JoAnne L Flynn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-11       Impact factor: 6.915

4.  Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.

Authors:  S Sharpe; A White; C Sarfas; L Sibley; F Gleeson; A McIntyre; R Basaraba; S Clark; G Hall; E Rayner; A Williams; P D Marsh; M Dennis
Journal:  Tuberculosis (Edinb)       Date:  2016-10-08       Impact factor: 3.131

5.  In vitro exposure system for study of aerosolized influenza virus.

Authors:  Hannah M Creager; Hui Zeng; Joanna A Pulit-Penaloza; Taronna R Maines; Terrence M Tumpey; Jessica A Belser
Journal:  Virology       Date:  2016-10-20       Impact factor: 3.616

6.  An aerosol challenge model of tuberculosis in Mauritian cynomolgus macaques.

Authors:  S A Sharpe; A D White; L Sibley; F Gleeson; G A Hall; R J Basaraba; A McIntyre; S O Clark; K Gooch; P D Marsh; A Williams; M J Dennis
Journal:  PLoS One       Date:  2017-03-08       Impact factor: 3.240

7.  High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation.

Authors:  Laura Sibley; Andrew D White; Karen E Gooch; Lisa M Stevens; Rachel Tanner; Ashley Jacobs; Owen Daykin-Pont; Fergus Gleeson; Anthony McIntyre; Randall Basaraba; Simon Clark; Graham Hall; Geoff Pearson; Emma Rayner; Helen McShane; Ann Williams; Mike Dennis; Philip D Marsh; Sally Sharpe
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.996

8.  Assessment of Mycobacterium bovis deleted in p27-p55 virulence operon as candidate vaccine against tuberculosis in animal models.

Authors:  María V Bianco; Simon Clark; Federico C Blanco; Sergio Garbaccio; Elizabeth García; Angel A Cataldi; Ann Williams; Fabiana Bigi
Journal:  Biomed Res Int       Date:  2014-01-21       Impact factor: 3.411

9.  Label-free optical vibrational spectroscopy to detect the metabolic state of M. tuberculosis cells at the site of disease.

Authors:  Vincent O Baron; Mingzhou Chen; Simon O Clark; Ann Williams; Robert J H Hammond; Kishan Dholakia; Stephen H Gillespie
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

10.  Non-replicating Mycobacterium tuberculosis elicits a reduced infectivity profile with corresponding modifications to the cell wall and extracellular matrix.

Authors:  Joanna Bacon; Luke J Alderwick; Jon A Allnutt; Evelina Gabasova; Robert Watson; Kim A Hatch; Simon O Clark; Rose E Jeeves; Alice Marriott; Emma Rayner; Howard Tolley; Geoff Pearson; Graham Hall; Gurdyal S Besra; Lorenz Wernisch; Ann Williams; Philip D Marsh
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.